Revolution Medicines Inc (RVMD) Sof marja

Ommaviy kompaniya RevMed (RVMD) logotipi

Revolution Medicines asosiy ishlanmalarga e'tibor qaratish uchun molekulalarni sintez qilish va sinovdan o'tkazishni tashqi hamkorlarga topshiradi. Sof foyda marjalari bunday xarajatlarning ta'sirini ko'rsatadi, -946.80 ko'rsatkichi esa joriy daromadlilik holatini belgilaydi. Barqarorlik xomashyo ta'minoti zanjirlarini nazorat qilish orqali ta'minlanadi va uzoq muddatli strategiya innovatsion mutatsiya inhibitorlarining tijoratga chiqarilishiga qaratilgan.

RVMD: revmed.com Sotuvning sof marjinal rentabelligi 04.07.2022 - 20.11.2026

Revolution Medicines Corp (RVMD) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning har tomonlama tahlili:Revolution Medicines
RevMed yetakchi tovari

Sof daromadlilik barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin tushumning qancha qismi yakuniy foydaga aylanganini belgilaydi va xarajatlarni boshqarish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Sof foyda marjasi tahlili, yuqori bozor kutuvlari va kelgusi klinik sinov bosqichlarining kapital intensivligini hisobga olgan holda, Revolution Medicines (RVMD) ning RAS inhibitorlarini ishlab chiqishdagi joriy muvaffaqiyatlari qanday qilib moliyaviy natijalarga aylanishini baholash imkonini beradi.

Muhim raqobatchilar

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja Ascentage Pharma Group|Sotuvning sof rentabelligi CGON (CG Oncology Corp)|Sof marja UroGen Pharma (URGN)|Sotuvning sof marjinal rentabelligi Bicara Therapeutics (BCAX)|Sotuvning sof marjinal rentabelligi PSNL (personalis.com)|Sof foyda normasi ERAS|DCTH: Sof foyda bo'yicha sotuv rentabelligi|YmAbs - Kompaniyaning sof rentabelligi|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)